214 related articles for article (PubMed ID: 12725607)
1. In patients with dermatitis herpetiformis distribution of transglutaminase in cutaneous tissue does not differ from controls.
Biagi F; Bassi E; Ardigó M; Vignini MA; Caravaggi M; Borroni G; Corazza GR
Dig Liver Dis; 2003 Jan; 35(1):41-5. PubMed ID: 12725607
[TBL] [Abstract][Full Text] [Related]
2. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
3. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis.
Sárdy M; Kárpáti S; Merkl B; Paulsson M; Smyth N
J Exp Med; 2002 Mar; 195(6):747-57. PubMed ID: 11901200
[TBL] [Abstract][Full Text] [Related]
4. Granular Deposits of IgA in the Skin of Coeliac Patients Without Dermatitis Herpetiformis: A Prospective Multicentric Analysis.
Antiga E; Maglie R; Lami G; Tozzi A; Bonciolini V; Calella F; Bianchi B; Del Bianco E; Renzi D; Mazzarese E; Calabrò AS; Caproni M
Acta Derm Venereol; 2021 Feb; 101(2):adv00382. PubMed ID: 33426564
[TBL] [Abstract][Full Text] [Related]
5. Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis.
Donaldson MR; Zone JJ; Schmidt LA; Taylor TB; Neuhausen SL; Hull CM; Meyer LJ
J Invest Dermatol; 2007 May; 127(5):1268-71. PubMed ID: 17205060
[No Abstract] [Full Text] [Related]
6. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
Dieterich W; Laag E; Bruckner-Tuderman L; Reunala T; Kárpáti S; Zágoni T; Riecken EO; Schuppan D
J Invest Dermatol; 1999 Jul; 113(1):133-6. PubMed ID: 10417632
[TBL] [Abstract][Full Text] [Related]
8. Dermatitis herpetiformis: close to unravelling a disease.
Kárpáti S
J Dermatol Sci; 2004 Apr; 34(2):83-90. PubMed ID: 15033190
[TBL] [Abstract][Full Text] [Related]
9. [Dermatitis herpetiformis].
Gjersvik PJ; Rønnevig JR
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3234-6. PubMed ID: 14714018
[TBL] [Abstract][Full Text] [Related]
10. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
[TBL] [Abstract][Full Text] [Related]
11. Granular IgA Deposits in the Skin of Patients with Coeliac Disease: Is it Always Dermatitis Herpetiformis?
Bonciolini V; Antiga E; Bianchi B; Del Bianco E; Ninci A; Maio V; Pimpinelli N; Caproni M
Acta Derm Venereol; 2019 Jan; 99(1):78-83. PubMed ID: 29972219
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
Preisz K; Sárdy M; Horváth A; Kárpáti S
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):74-9. PubMed ID: 15649195
[TBL] [Abstract][Full Text] [Related]
13. Recognition of epidermal transglutaminase by IgA and tissue transglutaminase 2 antibodies in a rare case of Rhesus dermatitis.
Sestak K; Mazumdar K; Midkiff CC; Dufour J; Borda JT; Alvarez X
J Vis Exp; 2011 Dec; (58):. PubMed ID: 22214930
[TBL] [Abstract][Full Text] [Related]
14. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
[TBL] [Abstract][Full Text] [Related]
15. Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.
Kemppainen E; Salmi T; Lindfors K
Front Immunol; 2021; 12():657280. PubMed ID: 33854513
[TBL] [Abstract][Full Text] [Related]
16. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding.
Byrne G; Ryan F; Jackson J; Feighery C; Kelly J
Gut; 2007 Mar; 56(3):336-41. PubMed ID: 16935926
[TBL] [Abstract][Full Text] [Related]
18. Co-localization of IgA and TG3 on healthy skin of coeliac patients.
Cannistraci C; Lesnoni La Parola I; Cardinali G; Bolasco G; Aspite N; Stigliano V; Picardo M
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):509-14. PubMed ID: 17373979
[TBL] [Abstract][Full Text] [Related]
19. Dermatitis herpetiformis and partial IgA deficiency.
Samolitis NJ; Hull CM; Leiferman KM; Zone JJ
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S206-9. PubMed ID: 16631941
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of Transglutaminase 3 in the IgA Aggregates in Dermatitis Herpetiformis Skin to Potassium Iodide.
Taylor TB; Zone JJ
J Invest Dermatol; 2018 Sep; 138(9):2066-2068. PubMed ID: 29571943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
